David Nierengarten, Managing Director, Wedbus...
In July, Biogen signed a potential $1 billion...
Avedro’s long saga with the FDA continues. ...
Dry eye remains one of the more dynamic secto...
Eleven Biotherapeutics last spring issued som...
The Ophthalmology Innovation Summit hit it bi...
Elisabeth “Eli” de los pinos was enjoying...
Allergan has been a pillar of the ophthalmolo...
OIS Correspondents Michelle Dalton and Richar...
Inotek CEO David Southwell and William K. McV...